Share this post on:

Product Name :
Vilanterol Trifenatate/Fluticasone Furoate/Glycopyrronium Bromide

Search keywords :
Vilanterol

drugId :
null

Target Vo:
Beta-2 adrenergic receptor

Target Vo Short Name :
ADRB2

Moa_Name:
Beta-2 adrenergic receptor agonists

First Approval Country :
India

First Approval Date Filter:
2023

Origin Company_Name :
Lupin Ltd

Active Company_Name :
Lupin Ltd

Active Indication_Name:
Pulmonary Disease, Chronic Obstructive

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
TAK1 (Y20P22) Mouse mAb manufacturer
Fasinumab Formula
Phospho-ATF2 (Thr71) Antibody: Phospho-ATF2 (Thr71) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to Phospho-ATF2 (Thr71). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Interleukin Related